Latest On Immunomedics, Inc (IMMU):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-10-23 17:52 EST | Insider Trade | Barbara Gayle Duncan has directly disposed of 49,244 shares and currently holds 0 shares. | Sell |  |
| 2020-10-23 17:52 EST | Insider Trade | CHARLES M BAUM has directly disposed of 9,667 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | BRYAN BALL has directly disposed of 10,000 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | Khalid Islam has directly disposed of 13,516 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | LORETTTA M ITRI has directly disposed of 15,000 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | PETER BARTON HUTT has directly disposed of 13,516 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | Scott A Canute has directly disposed of 13,516 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | Usama Malik has directly disposed of 18,856 shares and currently holds 0 shares. | Sell | |
| 2020-10-23 17:52 EST | Insider Trade | Behzad Aghazadeh has directly disposed of 13,516 shares and currently holds 0 shares. | Sell | |
| 2020-10-13 10:54 EST | News | Immunomedics's trodelvy nabs Orphan Drug tag for brain tumor in the U.S. | N/A | |
| 2020-10-03 01:08 EST | Analyst Rating | The Analyst Target Price has increased from $73.56 to $75.62. | Neutral | |
| 2020-09-26 13:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-21 23:51 EST | News | Immunomedics Trodelvy extends survival benefit in late-stage triple-negative breast cancer study | N/A | |
| 2020-09-21 23:51 EST | News | Immunomedics' trodelvy shows 27% response rate in urothelial cancer | N/A | |
| 2020-09-19 14:28 EST | News | Immunomedics antibody-drug conjugate shows encouraging action in brain tumors | N/A | |
| 2020-09-17 05:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-16 12:52 EST | Analyst Rating | The Analyst Target Price has increased from $66.96 to $73.56. | Neutral | |
| 2020-09-15 17:21 EST | News | Gilead Sciences And Immunomedics: Buy Post-Market Reaction | N/A | |
| 2020-09-15 17:20 EST | News | What Gilead's $21 Billion Oncology Bet Means For Investors | N/A | |
| 2020-09-15 17:18 EST | News | Gilead: Markets Like Deal For Immunomedics, And I Agree | N/A | |
| 2020-09-15 16:54 EST | Insider Trade | Barbara Gayle Duncan has directly acquired 2,500 shares and currently holds 39,577 shares. | Buy | |
| 2020-09-15 12:58 EST | Analyst Rating | The Analyst Target Price has increased from $52.24 to $66.96. | Neutral | |
| 2020-09-14 12:33 EST | News | Gilead to buy Immunomedics for $21B, bolstering its cancer arsenal | N/A | |
| 2020-09-14 12:33 EST | News | Gilead/Immunomedics deal lifts antibody-drug conjugate developers | N/A | |
| 2020-09-13 09:01 EST | News | Gilead nears $20B-plus deal to buy Immunomedics - WSJ | N/A | |
| 2020-08-20 16:24 EST | Insider Trade | Barbara Gayle Duncan has directly acquired 20,000 shares and currently holds 37,077 shares. | Buy | |
| 2020-08-14 16:56 EST | Insider Trade | Barbara Gayle Duncan has directly acquired 17,077 shares and currently holds 17,077 shares. | Buy | |
| 2020-08-14 09:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 00:58 EST | Analyst Rating | The Analyst Target Price has increased from $51.51 to $52.24. | Buy | |
| 2020-08-07 13:03 EST | Analyst Rating | The Analyst Target Price has increased from $48.96 to $51.51. | Buy | |
| 2020-08-07 08:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 19:27 EST | News | Immunomedics, Inc. (IMMU) Management on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-06 12:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-05 16:18 EST | News | Immunomedics Q2 Earnings Preview | N/A | |
| 2020-08-05 16:15 EST | News | Immunomedics EPS beats by $0.04, beats on revenue | N/A | |
| 2020-08-04 13:00 EST | Analyst Rating | The Analyst Target Price has increased from $48.78 to $48.96. | Buy | |
| 2020-07-31 01:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 05:02 EST | Analyst Rating | The Analyst Target Price has increased from $47.51 to $48.78. | Buy | |
| 2020-07-23 17:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-20 13:01 EST | Analyst Rating | The Analyst Target Price has increased from $46.05 to $47.51. | Buy | |
| 2020-07-14 13:50 EST | News | Immunomedics expands Roche partnership with two new trials | N/A | |
| 2020-07-09 09:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-08 12:52 EST | Analyst Rating | The Analyst Target Price has increased from $45.87 to $46.05. | Buy | |
| 2020-07-07 13:06 EST | Analyst Rating | The Analyst Target Price has increased from $41.6 to $45.87. | Buy | |
| 2020-07-07 10:56 EST | News | Immunomedics antibody-drug conjugate successful in late-stage breast cancer study | N/A | |
| 2020-07-07 10:55 EST | News | Immunomedics Positive Cancer Data, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-07-07 00:55 EST | Analyst Rating | The Analyst Target Price has increased from $40.2 to $41.6. | Buy | |
| 2020-07-03 11:57 EST | News | Immmunomedics +3.4% after setting clinical update for Monday | N/A | |
| 2020-07-02 10:23 EST | News | BofA fires off favorite stock picks for new quarter | N/A | |
| 2020-06-26 09:02 EST | Financials | Company financials have been released. | Neutral | |
About Immunomedics, Inc (IMMU):
Immunomedics, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products for the targeted treatment of cancer. It develops sacituzumab govitecan, an antibody-drug conjugate for the treatment of patients with metastatic triple-negative breast cancer. The company focuses on commercializing sacituzumab govitecan as a third-line therapy for patients with metastatic triple-negative breast cancer in the United States. The company also develops IMMU-140 for treatment of hematologic malignancies; and IMMU-130 to treat Colorectal cancer. Its other product candidates includes epratuzumab, an anti-CD22 antibody; veltuzumab, an anti-CD20 antibody; milatuzumab, an anti-CD74 antibody; and IMMU-114, a HLA-DR antibody. Immunomedics, Inc. has clinical collaboration with AstraZeneca and MedImmune to evaluate Imfinzi, a human monoclonal antibody against PD-L1, with sacituzumab govitecan as a frontline treatment of patients with TNBC and urothelial cancer; collaboration agreement with GBG Forschungs GmbH to develop sacituzumab govitecan for the treatment of breast cancer; and clinical collaboration with F. Hoffman-La Roche Ltd to treat patients with metastatic or inoperable locally advanced TNBC versus atezolizumab plus nab-paclitaxel as standard of care. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey. As of October 23, 2020, Immunomedics, Inc. operates as a subsidiary of Gilead Sciences, Inc.
General
- Name Immunomedics, Inc
- Symbol IMMU
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 366
- Last Split Factor2:1
- Last Split Date1985-06-24
- Fiscal Year EndDecember
- IPO Date1990-03-26
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.immunomedics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 895.13
- Price/Book (Most Recent Quarter) 34.23
- Enterprise Value Revenue 963.85
View More
Financials
- Most Recent Quarter 2020-06-30
- Current Year EPS Estimate -$1.11
- Next Year EPS Estimate -$0.58
- Operating Margin -1537%
- Return on Assets -25%
- Return on Equity -100%
- Revenue 20.37 million
- Earnings Per Share -$1.63
- Revenue Per Share $0.1
- Gross Profit -254576000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 20.31 billion
- EBITDA -340496000
- Analyst Target Price $75.62
- Book Value Per Share $2.57
View More
Share Statistics
- Shares Outstanding 231.16 million
- Shares Float 231 million
- % Held by Insiders 14%
- % Held by Institutions 81.31%
- Shares Short 23.6 million
- Shares Short Prior Month 26.65 million
- Short Ratio 2.85
- Short % of Float 11%
- Short % of Shares Outstanding 10%
View More
Technicals
- Beta 2.9
- 52 Week High $87.64
- 52 Week Low $8.01
- 50 Day Moving Average 80.77
- 200 Day Moving Average 46.84
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
Immunomedics, Inc (IMMU) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Immunomedics, Inc (IMMU) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-08-05 | $20.07 million | -$0.30 | -$0.34 | 11.76% |
| 2020-03-31 | 2020-05-06 | $N/A | -$0.44 | -$0.46 | 4.35% |
| 2019-12-31 | 2020-02-27 | $295000 | -$0.50 | -$0.46 | -8.7% |
| 2019-09-30 | 2019-10-30 | $N/A | -$0.49 | -$0.40 | -22.5% |
| 2019-06-30 | 2019-08-07 | $N/A | -$0.40 | -$0.30 | -33.33% |
| 2019-03-31 | 2019-05-09 | $N/A | -$0.46 | -$0.38 | -21.05% |
| 2018-12-31 | 2019-02-25 | $N/A | -$0.50 | -$0.34 | -47.06% |
| 2018-09-30 | 2018-11-07 | $-1673774 | -$0.34 | -$0.28 | -21.43% |
| 2018-06-30 | 2018-08-23 | $386000 | -$0.68 | -$0.21 | -223.81% |
| 2018-03-31 | 2018-05-09 | $2.41 million | -$0.21 | -$0.15 | -40% |
| 2017-12-31 | 2018-02-08 | $597284 | -$0.02 | -$0.12 | 83.33% |
| 2017-09-30 | 2017-11-09 | $5.06 million | -$0.97 | -$0.11 | -781.82% |
| 2017-06-30 | 2017-08-16 | $642000 | -$0.48 | -$0.12 | -300% |
| 2017-03-31 | 2017-05-10 | $1.32 million | -$0.55 | -$0.13 | -323.08% |
| 2016-12-31 | 2017-02-09 | $384000 | -$0.23 | -$0.13 | -76.92% |
| 2016-09-30 | 2016-11-02 | $742000 | -$0.17 | -$0.13 | -30.77% |
| 2016-06-30 | 2016-08-17 | $932000 | -$0.17 | -$0.11 | -54.55% |
| 2016-03-31 | 2016-05-04 | $899000 | -$0.17 | -$0.13 | -30.77% |
| 2015-12-31 | 2016-02-03 | $671000 | -$0.18 | -$0.13 | -38.46% |
| 2015-09-30 | 2015-11-04 | $731000 | -$0.16 | -$0.14 | -14.29% |
| 2015-06-30 | 2015-08-19 | $2.4 million | -$0.13 | -$0.13 | 0% |
| 2015-03-31 | 2015-05-06 | $1.18 million | -$0.13 | -$0.13 | 0% |
| 2014-12-31 | 2015-02-04 | $1 million | -$0.12 | -$0.13 | 7.69% |
| 2014-09-30 | 2014-11-05 | $1.07 million | -$0.13 | -$0.12 | -8.33% |
| 2014-06-30 | 2014-08-25 | $1.19 million | -$0.13 | -$0.12 | -8.33% |
| 2014-03-31 | 2014-05-07 | $1.16 million | -$0.11 | -$0.11 | 0% |
| 2013-12-31 | 2014-02-10 | $1.2 million | -$0.10 | -$0.10 | 0% |
| 2013-09-30 | 2013-11-04 | $5.5 million | -$0.05 | -$0.09 | 44.44% |
| 2013-06-30 | 2013-08-22 | $1.36 million | -$0.09 | -$0.12 | 25% |
| 2013-03-31 | 2013-05-08 | $1.74 million | -$0.11 | -$0.10 | -10% |
| 2012-12-31 | 2013-02-07 | $813000 | -$0.07 | -$0.09 | 22.22% |
| 2012-09-30 | 2012-11-08 | $1.05 million | -$0.10 | -$0.10 | 0% |
| 2012-06-30 | 2012-08-23 | $963000 | -$0.10 | -$0.09 | -11.11% |
| 2012-03-31 | 2012-05-08 | $971000 | -$0.10 | -$0.09 | -11.11% |
| 2011-12-31 | 2012-02-08 | $29.66 million | $0.27 | -$0.08 | 437.5% |
| 2011-09-30 | 2011-11-04 | $1.15 million | -$0.07 | -$0.09 | 22.22% |
| 2011-06-30 | 2011-08-24 | $11.12 million | $0.03 | -$0.06 | 150% |
| 2011-03-31 | 2011-05-10 | $1.1 million | -$0.10 | -$0.08 | -25% |
| 2010-12-31 | 2011-02-04 | $1 million | -$0.05 | -$0.08 | 37.5% |
| 2010-09-30 | 2010-11-04 | $1.49 million | -$0.09 | -$0.07 | -28.57% |
| 2010-06-30 | 2010-08-26 | $6.11 million | $0.01 | -$0.08 | 112.5% |
| 2010-03-31 | 2010-05-10 | $10.69 million | $0.05 | -$0.02 | 350% |
| 2009-12-31 | 2010-02-02 | $5.1 million | $0.01 | ||
| 2009-09-30 | 2009-11-06 | $39.03 million | $0.42 | $0.36 | 16.67% |
| 2009-06-30 | 2009-08-27 | $8.3 million | $0.01 | $0.01 | 0% |
| 2009-03-31 | 2009-05-11 | $8.31 million | $0.01 | -$0.02 | 150% |
| 2008-12-31 | 2009-02-09 | $8.51 million | $0.04 | -$0.01 | 500% |
| 2008-09-30 | 2008-11-07 | $4.9 million | -$0.03 | -$0.05 | 40% |
| 2008-06-30 | 2008-08-28 | $964000 | -$0.09 | -$0.06 | -50% |
| 2008-03-31 | 2008-05-07 | $904000 | -$0.11 | -$0.05 | -120% |
| 2007-12-31 | 2008-02-07 | $1 million | -$0.04 | -$0.09 | 55.56% |
| 2007-09-30 | 2007-11-06 | $781000 | -$0.06 | -$0.08 | 25% |
| 2007-06-30 | 2007-09-13 | $838000 | -$0.06 | -$0.08 | 25% |
| 2007-03-31 | 2007-05-08 | $939000 | -$0.08 | -$0.05 | -60% |
| 2006-12-31 | 2007-02-09 | $3.4 million | -$0.08 | ||
| 2006-09-30 | 2006-11-06 | $3.33 million | -$0.04 | ||
| 2006-06-30 | 2006-08-25 | $2.15 million | -$0.10 | -$0.17 | 41.18% |
| 2006-03-31 | 2006-05-10 | $1.32 million | -$0.10 | -$0.17 | 41.18% |
| 2005-12-31 | 2006-02-14 | $462000 | -$0.16 | -$0.16 | 0% |
| 2005-09-30 | 2005-11-07 | $423000 | -$0.16 | -$0.13 | -23.08% |
| 2005-06-30 | 2005-09-08 | $609000 | -$0.19 | -$0.11 | -72.73% |
| 2005-03-31 | 2005-05-05 | $1.09 million | -$0.11 | -$0.10 | -10% |
| 2004-12-31 | 2005-02-04 | $999000 | -$0.12 | -$0.10 | -20% |
| 2004-09-30 | 2004-11-03 | $1.12 million | -$0.08 | ||
| 2004-06-30 | 2004-09-08 | $912000 | -$0.14 | ||
| 2004-03-31 | 2004-05-11 | $1.15 million | -$0.11 | -$0.11 | 0% |
| 2003-12-31 | 2004-02-09 | $1.06 million | -$0.10 | -$0.09 | -11.11% |
| 2003-09-30 | 2003-11-13 | $1.19 million | -$0.10 | -$0.08 | -25% |
| 2003-06-30 | 2003-08-13 | $1.75 million | -$0.07 | -$0.09 | 22.22% |
| 2003-03-31 | 2003-05-08 | $5.62 million | $0.01 | -$0.05 | 120% |
| 2002-12-31 | 2003-02-10 | $3.12 million | -$0.04 | -$0.05 | 20% |
| 2002-09-30 | 2002-11-11 | $3.23 million | -$0.06 | -$0.03 | -100% |
| 2002-06-30 | 2002-08-12 | $4.3 million | -$0.04 | -$0.03 | -33.33% |
| 2002-03-31 | 2002-05-08 | $3.28 million | -$0.01 | ||
| 2001-12-31 | 2002-02-01 | $3.36 million | -$0.01 | -$0.01 | 0% |
| 2001-09-30 | 2001-11-09 | $3.34 million | $-0.00 | -$0.01 | 63% |
| 2001-06-30 | 2001-08-08 | $3.53 million | -$0.01 | -$0.01 | 0% |
| 2001-03-31 | 2001-05-08 | $2.39 million | $-0.00 | $0.31 | -100.23% |
| 2000-12-31 | 2001-02-08 | $1.1 million | -$0.05 | -$0.04 | -25% |
| 2000-09-30 | 2000-11-06 | $1.38 million | -$0.03 | -$0.05 | 40% |
| 2000-06-30 | 2000-08-15 | $975000 | -$0.05 | -$0.05 | 0% |
| 2000-03-31 | 2000-05-12 | $1.41 million | -$0.06 | -$0.05 | -20% |
| 1999-12-31 | 2000-02-14 | -$0.06 | -$0.06 | 0% | |
| 1999-09-30 | 1999-09-30 | -$0.06 | |||
| 1999-03-31 | 1999-03-31 | -$0.09 | |||
| 1998-12-31 | 1998-12-31 | -$0.07 | |||
| 1998-09-30 | 1998-09-30 | -$0.08 | |||
| 1994-06-30 | 1994-07-29 | -$0.11 | -$0.12 | 8.33% | |
| 1993-12-31 | 1994-01-28 | -$0.13 | -$0.15 | 13.33% | |
| 1993-09-30 | 1993-11-03 | -$0.13 | -$0.10 | -30% | |
| 1993-06-30 | 1993-08-04 | -$0.12 | -$0.09 | -33.33% | |
| 1993-03-31 | 1993-04-30 | -$0.07 | -$0.06 | -16.67% | |
| 1992-12-31 | 1993-01-29 | -$0.08 | -$0.05 | -60% |
Immunomedics, Inc (IMMU) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | 42.56 million | N/A | 254.87 million | N/A | 52.92 million |
| Income Before Tax | -66.5 million | N/A | -99.64 million | -94.32 million | -75.95 million |
| Selling General Administrative | 28.86 million | N/A | 16.73 million | 17.81 million | 14.25 million |
| Gross Profit | 18.41 million | N/A | 180.35 million | -68.96 million | -52.92 million |
| Ebit | -51.29 million | N/A | -91.25 million | -86.77 million | -67.17 million |
| Operating Income | -53.01 million | N/A | -91.25 million | -86.77 million | -67.17 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 20.07 million | N/A | 295000 | N/A | N/A |
| Cost of Revenue | 1.67 million | N/A | -180.05 million | 68.96 million | 52.92 million |
| Total Other Income Expense Net | N/A | N/A | -8.39 million | -7.55 million | -8.79 million |
| Net Income From Continuing Operations | -66.5 million | N/A | -99.64 million | -94.32 million | -75.95 million |
| Net Income Applicable to Common Shares | -66.47 million | -93.05 million | -99.61 million | -94.29 million | -75.95 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | -851000 | N/A | N/A | N/A | N/A |
| Change to Liabilities | 61.21 million | N/A | 29.98 million | N/A | 65 million |
| Total Cash Flow from Investing Activities | -851000 | -473000 | -335000 | -815000 | -3.64 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | 466.56 million | N/A | 339.07 million | 175000 | 6.11 million |
| Change to Operating Activities | -5.05 million | 2.75 million | -38.09 million | 16.82 million | -15.47 million |
| Change in Cash | 434.9 million | N/A | 246.07 million | -63.26 million | -10.03 million |
| Total Cash from Operating Activities | -30.82 million | -71.87 million | -92.66 million | -62.61 million | -12.5 million |
| Depreciation | 976000 | N/A | 795000 | 1.06 million | 1.1 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | -295000 | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 21.28 million | 17.46 million | 14.55 million | 13.8 million | 12.82 million |
| Capital Expenditures | 851000 | N/A | 335000 | 815000 | 3.64 million |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 484.9 million | N/A | 404.49 million | 388.37 million | 363.13 million |
| Total Stockholder Equity | 593.32 million | N/A | 268.26 million | 24.36 million | 115.53 million |
| Other Current Liabilities | N/A | N/A | 3.46 million | 3.14 million | 5.31 million |
| Total Assets | 1.08 billion | N/A | 671.72 million | 411.73 million | 477.69 million |
| Common Stock | 2.31 million | 2.14 million | 2.13 million | 1.92 million | 1.92 million |
| Other Current Assets | 3.79 million | N/A | 3.41 million | 1.31 million | 1.31 million |
| Retained Earnings | -1.47 billion | -1.4 billion | -1.31 billion | -1.21 billion | -1.12 billion |
| Other Liabilities | 393.86 million | 332.22 million | 332.73 million | 313.18 million | 301.35 million |
| Other Assets | 142000 | 233000 | 256000 | 267000 | 249000 |
| Cash | 971.19 million | N/A | 608.63 million | 364.65 million | 427.91 million |
| Total Current Liabilities | 81.26 million | N/A | 71.76 million | 58.05 million | 44.55 million |
| Other Stockholder Equity | -795000 | -802000 | -568000 | -601000 | -365000 |
| Property, Plant & Equipment | 33.51 million | 32.15 million | 32.76 million | 33.39 million | 35.18 million |
| Total Current Assets | 1.04 billion | N/A | 638.7 million | 378.08 million | 442.26 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 593.32 million | 185.97 million | 268.26 million | 24.36 million | 115.53 million |
| Short Term Investments | 4.33 million | N/A | 4.55 million | 4.55 million | 4.74 million |
| Long Term Debt | 267.65 million | N/A | N/A | 7.09 million | 7.08 million |
| Inventory | 20.81 million | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | 60.86 million | 54.6 million | 38.97 million |
Immunomedics, Inc (IMMU) Chart:
Immunomedics, Inc (IMMU) News:
Below you will find a list of latest news for Immunomedics, Inc (IMMU) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Immunomedics, Inc (IMMU) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Immunomedics, Inc (IMMU) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075724/0001104659-20-075724-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000008025519002446/0000080255-19-002446-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000008025520001066/0000080255-20-001066-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000021545719004091/0000215457-19-004091-index.htm |
| 2019-04-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000031506619001489/0000315066-19-001489-index.htm |
| 2019-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000031506619001610/0000315066-19-001610-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000031506620001044/0000315066-20-001044-index.htm |
| 2018-10-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/722830/000072283018000009/0000722830-18-000009-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/722830/000072283018000012/0000722830-18-000012-index.htm |
| 2019-02-25 | 10-KT | Transition reports [Rule 13a-10 or 15d-10] | https://www.sec.gov/Archives/edgar/data/722830/000072283019000005/0000722830-19-000005-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/722830/000072283019000008/0000722830-19-000008-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/722830/000072283019000012/0000722830-19-000012-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/722830/000072283019000016/0000722830-19-000016-index.htm |
| 2019-10-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/722830/000072283019000020/0000722830-19-000020-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/722830/000072283020000003/0000722830-20-000003-index.htm |
| 2020-04-15 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/722830/000072283020000008/0000722830-20-000008-index.htm |
| 2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/722830/000072283020000012/0000722830-20-000012-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/722830/000072283020000017/0000722830-20-000017-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/722830/000072283020000023/0000722830-20-000023-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000083423720005297/0000834237-20-005297-index.htm |
| 2020-04-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000089914020000245/0000899140-20-000245-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000090266419002373/0000902664-19-002373-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000090266419002619/0000902664-19-002619-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000090266419002892/0000902664-19-002892-index.htm |
| 2019-07-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/722830/000090266419002896/0000902664-19-002896-index.htm |
| 2019-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000090266419003903/0000902664-19-003903-index.htm |
| 2019-12-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000090266419004538/0000902664-19-004538-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000090266420001946/0000902664-20-001946-index.htm |
| 2020-10-23 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/722830/000090266420003744/0000902664-20-003744-index.htm |
| 2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000093247119005439/0000932471-19-005439-index.htm |
| 2020-09-14 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/722830/000095010320017824/0000950103-20-017824-index.htm |
| 2020-09-14 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/722830/000095010320017910/0000950103-20-017910-index.htm |
| 2020-09-15 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/722830/000095010320018043/0000950103-20-018043-index.htm |
| 2020-09-16 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/722830/000095010320018109/0000950103-20-018109-index.htm |
| 2020-09-17 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/722830/000095010320018221/0000950103-20-018221-index.htm |
| 2020-09-24 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/722830/000095010320018605/0000950103-20-018605-index.htm |
| 2020-09-24 | SC TO-T | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/722830/000104746920004976/0001047469-20-004976-index.htm |
| 2018-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465918059441/0001104659-18-059441-index.htm |
| 2018-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465918060186/0001104659-18-060186-index.htm |
| 2018-12-06 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/722830/000110465918071491/0001104659-18-071491-index.htm |
| 2018-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465918073357/0001104659-18-073357-index.htm |
| 2018-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465918074647/0001104659-18-074647-index.htm |
| 2018-12-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465918075005/0001104659-18-075005-index.htm |
| 2019-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919002140/0001104659-19-002140-index.htm |
| 2019-01-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919002351/0001104659-19-002351-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919006351/0001104659-19-006351-index.htm |
| 2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919007162/0001104659-19-007162-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919010339/0001104659-19-010339-index.htm |
| 2019-02-26 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919010444/0001104659-19-010444-index.htm |
| 2019-02-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919010761/0001104659-19-010761-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919010762/0001104659-19-010762-index.htm |
| 2019-03-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919013433/0001104659-19-013433-index.htm |
| 2019-03-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919013434/0001104659-19-013434-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919013436/0001104659-19-013436-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919013437/0001104659-19-013437-index.htm |
| 2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919013499/0001104659-19-013499-index.htm |
| 2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919013868/0001104659-19-013868-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919013869/0001104659-19-013869-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919014587/0001104659-19-014587-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015612/0001104659-19-015612-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015613/0001104659-19-015613-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015615/0001104659-19-015615-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015616/0001104659-19-015616-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015617/0001104659-19-015617-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015619/0001104659-19-015619-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919015621/0001104659-19-015621-index.htm |
| 2019-03-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/722830/000110465919018748/0001104659-19-018748-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919018749/0001104659-19-018749-index.htm |
| 2019-04-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919020011/0001104659-19-020011-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919020248/0001104659-19-020248-index.htm |
| 2019-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919021385/0001104659-19-021385-index.htm |
| 2019-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919021967/0001104659-19-021967-index.htm |
| 2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919024298/0001104659-19-024298-index.htm |
| 2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919024301/0001104659-19-024301-index.htm |
| 2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919033140/0001104659-19-033140-index.htm |
| 2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919034570/0001104659-19-034570-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919034786/0001104659-19-034786-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919034787/0001104659-19-034787-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919034788/0001104659-19-034788-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919034791/0001104659-19-034791-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919034792/0001104659-19-034792-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919034793/0001104659-19-034793-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919036862/0001104659-19-036862-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049586/0001104659-19-049586-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049587/0001104659-19-049587-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049588/0001104659-19-049588-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049589/0001104659-19-049589-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049590/0001104659-19-049590-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049591/0001104659-19-049591-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919049592/0001104659-19-049592-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919053001/0001104659-19-053001-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465919065857/0001104659-19-065857-index.htm |
| 2019-12-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/722830/000110465919069600/0001104659-19-069600-index.htm |
| 2019-12-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/722830/000110465919070248/0001104659-19-070248-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465919071004/0001104659-19-071004-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000110465920018397/0001104659-20-018397-index.htm |
| 2020-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920020779/0001104659-20-020779-index.htm |
| 2020-02-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920022513/0001104659-20-022513-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920022514/0001104659-20-022514-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920026184/0001104659-20-026184-index.htm |
| 2020-02-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920026242/0001104659-20-026242-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920026244/0001104659-20-026244-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920029755/0001104659-20-029755-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920029756/0001104659-20-029756-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920029758/0001104659-20-029758-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920029759/0001104659-20-029759-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920029760/0001104659-20-029760-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920037009/0001104659-20-037009-index.htm |
| 2020-04-20 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920048724/0001104659-20-048724-index.htm |
| 2020-04-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920048725/0001104659-20-048725-index.htm |
| 2020-04-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920048727/0001104659-20-048727-index.htm |
| 2020-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/722830/000110465920051572/0001104659-20-051572-index.htm |
| 2020-04-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/722830/000110465920051608/0001104659-20-051608-index.htm |
| 2020-04-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/722830/000110465920054444/0001104659-20-054444-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920055660/0001104659-20-055660-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920057760/0001104659-20-057760-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920066388/0001104659-20-066388-index.htm |
| 2020-05-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/722830/000110465920066399/0001104659-20-066399-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920074657/0001104659-20-074657-index.htm |
| 2020-06-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/722830/000110465920074695/0001104659-20-074695-index.htm |
| 2020-06-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/722830/000110465920074698/0001104659-20-074698-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075692/0001104659-20-075692-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075693/0001104659-20-075693-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075694/0001104659-20-075694-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075695/0001104659-20-075695-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075696/0001104659-20-075696-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075697/0001104659-20-075697-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920075724/0001104659-20-075724-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920095587/0001104659-20-095587-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920097230/0001104659-20-097230-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920104608/0001104659-20-104608-index.htm |
| 2020-09-14 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/722830/000110465920104908/0001104659-20-104908-index.htm |
| 2020-09-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920105255/0001104659-20-105255-index.htm |
| 2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920106127/0001104659-20-106127-index.htm |
| 2020-09-24 | SC 14D9 | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/722830/000110465920108121/0001104659-20-108121-index.htm |
| 2020-09-25 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/722830/000110465920108931/0001104659-20-108931-index.htm |
| 2020-09-25 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/722830/000110465920108948/0001104659-20-108948-index.htm |
| 2020-10-02 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/722830/000110465920111772/0001104659-20-111772-index.htm |
| 2020-10-02 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/722830/000110465920111777/0001104659-20-111777-index.htm |
| 2020-10-13 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/722830/000110465920114566/0001104659-20-114566-index.htm |
| 2020-10-13 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/722830/000110465920114569/0001104659-20-114569-index.htm |
| 2020-10-14 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/722830/000110465920114725/0001104659-20-114725-index.htm |
| 2020-10-14 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/722830/000110465920114726/0001104659-20-114726-index.htm |
| 2020-10-23 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/722830/000110465920117410/0001104659-20-117410-index.htm |
| 2020-10-23 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/722830/000110465920117414/0001104659-20-117414-index.htm |
| 2020-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000110465920117764/0001104659-20-117764-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117777/0001104659-20-117777-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117778/0001104659-20-117778-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117779/0001104659-20-117779-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117780/0001104659-20-117780-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117781/0001104659-20-117781-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117783/0001104659-20-117783-index.htm |
| 2020-10-23 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/722830/000110465920117784/0001104659-20-117784-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117792/0001104659-20-117792-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117793/0001104659-20-117793-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117794/0001104659-20-117794-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117795/0001104659-20-117795-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117796/0001104659-20-117796-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117797/0001104659-20-117797-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117798/0001104659-20-117798-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117800/0001104659-20-117800-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117801/0001104659-20-117801-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117802/0001104659-20-117802-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117803/0001104659-20-117803-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117805/0001104659-20-117805-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920117806/0001104659-20-117806-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117808/0001104659-20-117808-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117809/0001104659-20-117809-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117810/0001104659-20-117810-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117811/0001104659-20-117811-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117812/0001104659-20-117812-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117815/0001104659-20-117815-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117872/0001104659-20-117872-index.htm |
| 2020-10-26 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/722830/000110465920117876/0001104659-20-117876-index.htm |
| 2020-10-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/722830/000110465920118646/0001104659-20-118646-index.htm |
| 2020-11-02 | 15-12G | Securities registration termination [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/722830/000110465920120270/0001104659-20-120270-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184318007709/0001171843-18-007709-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184319003165/0001171843-19-003165-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184319005252/0001171843-19-005252-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184319006184/0001171843-19-006184-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184319006960/0001171843-19-006960-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184319007907/0001171843-19-007907-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184319008312/0001171843-19-008312-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320001344/0001171843-20-001344-index.htm |
| 2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320001965/0001171843-20-001965-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320002375/0001171843-20-002375-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320002378/0001171843-20-002378-index.htm |
| 2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320002751/0001171843-20-002751-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320003373/0001171843-20-003373-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320004747/0001171843-20-004747-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320005563/0001171843-20-005563-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320005961/0001171843-20-005961-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/722830/000117184320006524/0001171843-20-006524-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/722830/000117266119000436/0001172661-19-000436-index.htm |
| 2020-10-23 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/722830/000135445720000622/0001354457-20-000622-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003015/9999999995-20-003015-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003016/9999999995-20-003016-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003017/9999999995-20-003017-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003018/9999999995-20-003018-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003019/9999999995-20-003019-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003020/9999999995-20-003020-index.htm |
| 2020-10-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/722830/999999999520003038/9999999995-20-003038-index.htm |
| 2018-11-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/722830/999999999718009024/9999999997-18-009024-index.htm |
| 2018-12-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/722830/999999999718009352/9999999997-18-009352-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/722830/999999999719001418/9999999997-19-001418-index.htm |
Immunomedics, Inc (IMMU) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunomedics, Inc (IMMU). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 14%Institutional Ownership: 8131%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-23 | Barbara Gayle Duncan | Director | Sell | 49,244.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117792/0001104659-20-117792-index.htm | ||
| 2020-10-23 | Behzad Aghazadeh | Director | Sell | 13,516.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117806/0001104659-20-117806-index.htm | ||
| 2020-10-23 | BRYAN BALL | Chief Quality Officer | Sell | 10,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117796/0001104659-20-117796-index.htm | ||
| 2020-10-23 | CHARLES M BAUM | Director | Sell | 9,667.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117793/0001104659-20-117793-index.htm | ||
| 2020-10-23 | Khalid Islam | Director | Sell | 13,516.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117797/0001104659-20-117797-index.htm | ||
| 2020-10-23 | LORETTTA M ITRI | Chief Medical Officer | Sell | 15,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117800/0001104659-20-117800-index.htm | ||
| 2020-10-23 | PETER BARTON HUTT | Director | Sell | 13,516.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117801/0001104659-20-117801-index.htm | ||
| 2020-10-23 | Scott A Canute | Director | Sell | 13,516.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117803/0001104659-20-117803-index.htm | ||
| 2020-10-23 | Usama Malik | Chief Fin. & Business Officer | Sell | 18,856.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920117805/0001104659-20-117805-index.htm | ||
| 2019-10-03 | BRYAN BALL | Chief Quality Officer | Buy | 5,000.00 | 14.18 | 70,896.50 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919053001/0001104659-19-053001-index.htm |
| 2020-03-20 | Behzad Aghazadeh | Director | Buy | 100,000.00 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920037009/0001104659-20-037009-index.htm | ||
| 2020-06-18 | Barbara Gayle Duncan | Director | Buy | 3,718.00 | 13,385.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075694/0001104659-20-075694-index.htm | ||
| 2020-06-18 | CHARLES M BAUM | Director | Buy | 3,718.00 | 13,385.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075697/0001104659-20-075697-index.htm | ||
| 2019-06-07 | Behzad Aghazadeh | Director | Buy | 9,667.00 | 13,516.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919034793/0001104659-19-034793-index.htm | ||
| 2019-06-07 | Khalid Islam | Director | Buy | 9,667.00 | 13,516.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919034792/0001104659-19-034792-index.htm | ||
| 2019-06-07 | PETER BARTON HUTT | Director | Buy | 9,667.00 | 13,516.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919034788/0001104659-19-034788-index.htm | ||
| 2019-06-07 | Scott A Canute | Director | Buy | 9,667.00 | 13,516.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919034787/0001104659-19-034787-index.htm | ||
| 2020-08-12 | Barbara Gayle Duncan | Director | Buy | 17,077.00 | 12.93 | 220,805.61 | 17,077.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920095587/0001104659-20-095587-index.htm |
| 2020-06-18 | Behzad Aghazadeh | Director | Buy | 3,718.00 | 17,234.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075724/0001104659-20-075724-index.htm | ||
| 2020-06-18 | Khalid Islam | Director | Buy | 3,718.00 | 17,234.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075695/0001104659-20-075695-index.htm | ||
| 2020-06-18 | PETER BARTON HUTT | Director | Buy | 3,718.00 | 17,234.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075696/0001104659-20-075696-index.htm | ||
| 2020-06-18 | Scott A Canute | Director | Buy | 3,718.00 | 17,234.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075693/0001104659-20-075693-index.htm | ||
| 2019-05-13 | Avoro Capital Advisors LLC | Director | Buy | 500,000.00 | 15.07 | 7,535,000.00 | 18,214,461.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002373/0000902664-19-002373-index.htm |
| 2019-05-14 | Avoro Capital Advisors LLC | Director | Buy | 125,000.00 | 15.40 | 1,925,000.00 | 18,339,461.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002373/0000902664-19-002373-index.htm |
| 2019-05-15 | Avoro Capital Advisors LLC | Director | Buy | 125,000.00 | 14.95 | 1,868,750.00 | 18,464,461.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002373/0000902664-19-002373-index.htm |
| 2019-06-03 | Avoro Capital Advisors LLC | Director | Buy | 785,539.00 | 12.19 | 9,575,720.41 | 19,250,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002619/0000902664-19-002619-index.htm |
| 2019-06-04 | Avoro Capital Advisors LLC | Director | Buy | 500,000.00 | 12.10 | 6,050,000.00 | 19,750,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002619/0000902664-19-002619-index.htm |
| 2019-06-05 | Avoro Capital Advisors LLC | Director | Buy | 250,000.00 | 12.47 | 3,117,500.00 | 20,000,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002619/0000902664-19-002619-index.htm |
| 2019-06-26 | Avoro Capital Advisors LLC | Director | Buy | 400,000.00 | 13.25 | 5,300,000.00 | 20,400,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002892/0000902664-19-002892-index.htm |
| 2019-06-27 | Avoro Capital Advisors LLC | Director | Buy | 350,000.00 | 13.68 | 4,788,000.00 | 20,750,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002892/0000902664-19-002892-index.htm |
| 2019-06-28 | Avoro Capital Advisors LLC | Director | Buy | 250,000.00 | 13.84 | 3,460,000.00 | 21,000,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419002892/0000902664-19-002892-index.htm |
| 2019-10-02 | Avoro Capital Advisors LLC | Director | Buy | 1,000,000.00 | 13.23 | 13,230,000.00 | 22,000,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419003903/0000902664-19-003903-index.htm |
| 2019-10-03 | Avoro Capital Advisors LLC | Director | Buy | 500,000.00 | 14.10 | 7,050,000.00 | 22,500,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419003903/0000902664-19-003903-index.htm |
| 2019-12-05 | Avoro Capital Advisors LLC | Director | Buy | 2,000,000.00 | 17.50 | 35,000,000.00 | 24,500,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266419004538/0000902664-19-004538-index.htm |
| 2020-05-01 | Avoro Capital Advisors LLC | Director | Buy | 1,750,000.00 | 28.50 | 49,875,000.00 | 26,250,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000090266420001946/0000902664-20-001946-index.htm |
| 2020-08-17 | Barbara Gayle Duncan | Director | Buy | 20,000.00 | 16.96 | 339,200.00 | 37,077.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920097230/0001104659-20-097230-index.htm |
| 2020-06-18 | Robert Azelby | Director | Buy | 3,718.00 | 3,718.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920075692/0001104659-20-075692-index.htm | ||
| 2020-09-14 | Barbara Gayle Duncan | Director | Buy | 2,500.00 | 16.96 | 42,400.00 | 39,577.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920105255/0001104659-20-105255-index.htm |
| 2019-06-20 | BRYAN BALL | Chief Quality Officer | Buy | 5,000.00 | 13.35 | 66,750.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919036862/0001104659-19-036862-index.htm |
| 2020-04-16 | Harout Semerjian | President and CEO | Buy | 50,075.00 | 50,075.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465920048727/0001104659-20-048727-index.htm | ||
| 2019-06-07 | Barbara Gayle Duncan | Director | Buy | 9,667.00 | 9,667.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919034791/0001104659-19-034791-index.htm | ||
| 2019-06-07 | CHARLES M BAUM | Director | Buy | 9,667.00 | 9,667.00 | https://www.sec.gov/Archives/edgar/data/722830/000110465919034786/0001104659-19-034786-index.htm |